Literature DB >> 25587735

Extensive placental choriovascular infiltration by maturing myeloid cells in down syndrome-associated transient abnormal myelopoiesis.

Sanjita Ravishankar1, Laurie Hoffman, Terakeith Lertsburapa, Jennifer Welch, Diana Treaba, Monique E De Paepe.   

Abstract

Transient abnormal myelopoiesis (TAM), a clonal proliferation of predominantly megakaryocytic precursor cells, affects 4%-10% of newborns with Down syndrome. Approximately 20%-30% of TAM survivors are at risk of development of acute myeloid leukemia (myeloid leukemia associated with Down syndrome, ML-DS). We report unusual placental findings in a female infant with trisomy 21 born at 38 weeks of gestation. In line with previous descriptions of placental pathology in infants with TAM, abundant blast-like cells were present in the lumen of chorionic and stem villous vessels. In addition, there was multifocal extensive infiltration of the wall of chorionic vessels by maturing myeloid cells in a pattern reminiscent of TAM- or leukemia-associated systemic infiltration. The clinical significance of this unusual choriovascular involvement of the placenta in TAM is undetermined.

Entities:  

Keywords:  GATA1; congenital leukemia; transient myeloproliferative disorder; trisomy 21; vasculitis

Mesh:

Year:  2015        PMID: 25587735     DOI: 10.2350/14-11-1575-CR.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  2 in total

1.  Myeloid cell thrombus and fetal vascular malperfusion in placentas with transient abnormal myelopoiesis.

Authors:  Kayo Tomimori; Yuki Kodama; Hiroyuki Tanaka; Atushi Yamashita; Toshihiro Gi; Yujiro Asada; Koutarou Doi; Shinji Katsuragi; Yuichiro Sato
Journal:  Virchows Arch       Date:  2022-02-24       Impact factor: 4.064

2.  Novel insights from fetal and placental phenotyping in 3 mouse models of Down syndrome.

Authors:  April D Adams; Victoria Hoffmann; Laura Koehly; Faycal Guedj; Diana W Bianchi
Journal:  Am J Obstet Gynecol       Date:  2021-03-22       Impact factor: 10.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.